Bio Techne exotic insider transaction detected
| TECH Stock | USD 64.25 1.66 2.52% |
Under 61% of Bio Techne's investor base is looking to short. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that many investors are alarmed at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.
Filed transaction by Biotechne Corp director. Unconventional Insider trading
Read at macroaxis.com
Bio Techne Fundamental Analysis
We analyze Bio Techne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Bio Techne is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Bio Techne Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Techne stock to make a market-neutral strategy. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with similar companies.
Peers
Bio Techne Related Equities
| RVMD | Revolution Medicines | 6.44 | ||||
| VRNA | Verona Pharma | 6.02 | ||||
| MDGL | Madrigal Pharmaceuticals | 3.39 | ||||
| EXEL | Exelixis | 3.28 | ||||
| JAZZ | Jazz Pharmaceuticals | 0.58 | ||||
| CORT | Corcept Therapeutics | 0.06 | ||||
| MRNA | Moderna | 0.30 | ||||
| HALO | Halozyme Therapeutics | 0.45 | ||||
| CAI | Caris Life | 2.64 | ||||
| BMRN | Biomarin Pharmaceutical | 3.32 |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |